Shizuoka, Japan

Chie Kato

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chie Kato: Innovator in Cancer Research

Introduction

Chie Kato is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of cancer research through her innovative work. Her dedication to developing effective anti-cancer agents has led to the creation of a unique non-human animal model that closely mimics human cancer pathology.

Latest Patents

Chie Kato holds a patent for a method that involves searching and screening for targets of anti-cancer agents using a non-human animal model with a NOG-established cancer cell line transplanted within. The objective of this invention is to provide non-human animal models that replicate the hierarchical organization, cancer progression process, and biological properties of human cancer tissues. The research demonstrated that these models exhibit pathologies similar to those found in human cancer, thereby enhancing the understanding of cancer development and treatment.

Career Highlights

Throughout her career, Chie Kato has been associated with Chugai Seiyaku Kabushiki Kaisha, where she has contributed to groundbreaking research in oncology. Her work has not only advanced scientific knowledge but has also paved the way for potential therapeutic applications in cancer treatment.

Collaborations

Chie Kato has collaborated with notable colleagues, including Masami Suzuki and Koichi Matsubara. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in cancer research.

Conclusion

Chie Kato's contributions to cancer research through her innovative patent and collaborative efforts highlight her role as a key figure in the scientific community. Her work continues to inspire advancements in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…